Bentleigh East, Australia

Eric Dale Jones

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Eric Dale Jones: Innovator in Antiviral Compounds

Introduction

Eric Dale Jones is a prominent inventor based in Bentleigh East, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of seven patents to his name, Jones has established himself as a key figure in innovative medical research.

Latest Patents

Among his latest patents, Jones has developed compounds such as bicyclic pyrimidinones, which are designed for the treatment and prophylaxis of viral infections. The invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt, or prodrug thereof. Additionally, it includes a method of treatment that involves administering an effective amount of this compound to a subject. Another notable patent focuses on compounds having antiviral properties, again providing a compound of formula (I) for similar therapeutic applications.

Career Highlights

Jones is currently associated with Avexa Limited, a company dedicated to advancing pharmaceutical innovations. His work has been instrumental in creating effective treatments for viral infections, showcasing his commitment to improving public health through scientific research.

Collaborations

Some of his notable coworkers include David Ian Rhodes and John Joseph Deadman, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Eric Dale Jones continues to be a driving force in the development of antiviral medications, with his innovative patents paving the way for future advancements in the field. His contributions are vital in the ongoing fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…